Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.

Toshiyoshi Fujiwara, Noriaki Tanaka

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Replication-selective tumor-specific viruses present a novel approach for treatment of neoplastic disease. Telomerase activation is considered to be a critical step in carcinogenesis and its activity correlates closely with human telomerase reverse transcriptase (hTERT) expression. We constructed an attenuated adenovirus 5 vector (Telomelysin, OBP-301), in which the hTERT promoter element drives expression of E1 genes. Telomelysin replicated efficiently and induced marked cell killing in a panel of human cancer cell lines, whereas replication as well as cytotoxicity was highly attenuated in normal human cells lacking telomerase activity. We further modified the E3 region of OBP-301 to contain green fluorescent protein (GFP) gene for monitoring viral replication (TelomeScan, OBP-401). When TelomeScan was intratumorally injected into human tumors orthotopically implanted into the rectum in mice, para-aortic lymph node metastasis could be visualized at laparotomy under a three-chip color cooled charged-coupled device camera. This article reviews recent highlights in this rapidly evolving field: cancer therapeutic and cancer diagnostic approaches using the telomerase-specific oncolytic adenoviruses.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalUirusu. Journal of virology
Volume58
Issue number1
DOIs
Publication statusPublished - Jun 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.'. Together they form a unique fingerprint.

  • Cite this